459 related articles for article (PubMed ID: 17048517)
1. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility.
Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM
J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.
Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V
Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382
[TBL] [Abstract][Full Text] [Related]
3. Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles.
Grassi G; Coceani N; Farra R; Dapas B; Racchi G; Fiotti N; Pascotto A; Rehimers B; Guarnieri G; Grassi M
Int J Nanomedicine; 2006; 1(4):523-33. PubMed ID: 17722283
[TBL] [Abstract][Full Text] [Related]
4. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect.
Yang H; Li K; Liu Y; Liu Z; Miyoshi H
J Nanosci Nanotechnol; 2009 Jan; 9(1):282-7. PubMed ID: 19441308
[TBL] [Abstract][Full Text] [Related]
5. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
Grabovac V; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
[TBL] [Abstract][Full Text] [Related]
7. Intracellular delivery of cysteine protease inhibitor cystatin by polymeric nanoparticles.
Cegnar M; Kos J; Kristl J
J Nanosci Nanotechnol; 2006; 6(9-10):3087-94. PubMed ID: 17048522
[TBL] [Abstract][Full Text] [Related]
8. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
Ravi Kumar MN; Bakowsky U; Lehr CM
Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
[TBL] [Abstract][Full Text] [Related]
10. Permeation of PLGA nanoparticles across different in vitro models.
Nkabinde LA; Shoba-Zikhali LN; Semete-Makokotlela B; Kalombo L; Swai HS; Hayeshi R; Naicker B; Hillie TK; Hamman JH
Curr Drug Deliv; 2012 Nov; 9(6):617-27. PubMed ID: 22812395
[TBL] [Abstract][Full Text] [Related]
11. BCNU-loaded poly(D, L-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro.
Seong H; An TK; Khang G; Choi SU; Lee CO; Lee HB
Int J Pharm; 2003 Jan; 251(1-2):1-12. PubMed ID: 12527170
[TBL] [Abstract][Full Text] [Related]
12. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery.
Xin Y; Liu T; Yang C
Int J Nanomedicine; 2016; 11():5807-5821. PubMed ID: 27853366
[TBL] [Abstract][Full Text] [Related]
13. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
Mehta AK; Yadav KS; Sawant KK
Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
[TBL] [Abstract][Full Text] [Related]
14. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
15. Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium.
Horisawa E; Kubota K; Tuboi I; Sato K; Yamamoto H; Takeuchi H; Kawashima Y
Pharm Res; 2002 Feb; 19(2):132-9. PubMed ID: 11883639
[TBL] [Abstract][Full Text] [Related]
16. Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo.
Duan Y; Sun X; Gong T; Wang Q; Zhang Z
J Mater Sci Mater Med; 2006 Jun; 17(6):509-16. PubMed ID: 16691348
[TBL] [Abstract][Full Text] [Related]
17. Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance.
Kim WU; Lee WK; Ryoo JW; Kim SH; Kim J; Youn J; Min SY; Bae EY; Hwang SY; Park SH; Cho CS; Park JS; Kim HY
Arthritis Rheum; 2002 Apr; 46(4):1109-20. PubMed ID: 11953991
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran.
Jeong YI; Choi KC; Song CE
Arch Pharm Res; 2006 Aug; 29(8):712-9. PubMed ID: 16964768
[TBL] [Abstract][Full Text] [Related]
19. Studying the effect of physically-adsorbed coating polymers on the cytotoxic activity of optimized bisdemethoxycurcumin loaded-PLGA nanoparticles.
Mehanny M; Hathout RM; Geneidi AS; Mansour S
J Biomed Mater Res A; 2017 May; 105(5):1433-1445. PubMed ID: 28177570
[TBL] [Abstract][Full Text] [Related]
20. Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility.
Bertram JP; Jay SM; Hynes SR; Robinson R; Criscione JM; Lavik EB
Acta Biomater; 2009 Oct; 5(8):2860-71. PubMed ID: 19433141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
